Skip to main content
Premium Trial:

Request an Annual Quote

You’ve Got GT on the Brain

Premium

Just a few years ago, words with the prefix “neuro” weren’t all that common among genomic and proteomic scientists. When we thought about doing theme issues for Genome Technology, cancer was an obvious choice — but after that, no particular research target was really universal enough to merit its own magazine.

Times certainly have changed. From using comparative genomics for figuring out how the human brain evolved to tracking the movement of every protein in the brain, the people and tools that comprise systems biology have come out in full force to make neuroscience their own.

In this special issue of GT, we offer a number of ways to see what’s going on in neuro research. Our cover story, planned by senior editor Jen Crebs (who, helpfully, once worked in a leading neuroscience lab), features a number of cutting-edge scientists whose work relies on gene expression, RNAi, and proteomics, to name a few. It’s far from comprehensive, but should serve as a good sampling of some of the most innovative brain research from systems biology disciplines. Many thanks to Jen, whose excellent planning and hard work may have shrunk her hippocampus but led to a story I think you’ll find quite valuable.

We also serve up a profile of Janelia Farm, Howard Hughes Medical Institute’s big-ticket play in high-risk, high-reward research. Scientists at the Farm focus on neuroscience and imaging — and they never have to write a grant. Our Pattern Recognition column offers a look at some recent grants made in genomics, proteomics, and RNAi efforts targeting the brain. And finally, we are lucky to have Mike Hawrylycz, informatics director at the Allen Institute for Brain Science, as our guest columnist for this month’s Informatics Insider. Hawrylycz discusses the informatics challenges in building the recently launched final version of the Allen Brain Atlas, a 3D map of gene expression in the mouse brain.

So the brain isn’t your thing? We’ve got a feature story this month on RNAi delivery. Ever since this field exploded, “clinic” has been the magic word for grants as well as private-sector funding. But the delivery dilemma still stands between good science and the bedside, as researchers just aren’t sure how to reliably and accurately send siRNAs or shRNAs into patients. (As one scientist moaned: If only humans had tails!) Check out that story for the latest efforts to make RNAi an effective medical treatment.

Finally, for a little fun, our humor page is a guide to Halloween — with the harried scientist in mind. If you, like me, remember this holiday only when someone says, “Hey, what costume are you wearing tonight?”, then we’ve got your back. Check out p. 50 for the best time-saving approaches.

 

Meredith W. Salisbury, Editor

What do you think of Genome Technology? Let me know how we’re doing by e-mailing me at [email protected] or by calling me at +1.212.651.5635.

The Scan

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.